Treatments for severe brain diseases like Alzheimer’s, epilepsy and schizophrenia could be fast-tracked with a prototype research platform under development by a collaboration of Australian and international academics and science firms.
Four quantum computing and advanced biotechnology companies and Australia’s top-ranked university on Wednesday announced they would partner to develop a quantum-enabled brain-on-chip platform for neurological disease research.
The consortium consists of UK-based firm Axol Biosciences, Melbourne-based biotechs Chromos Labs …
Want to know how this story ends?
Become a subscriber for complete access to all stories on InnovationAus.com and our daily newsletter.
Already a member? Log in here
Do you know more? Contact James Riley via Email.